RecruitingNCT06812091

Human Microbiome Research and Development for Overcoming Pediatric Diseases

Prediction and Treatment of Pediatric Diseases and Long-term Outcomes Through Microbiome and Multi-Omics Study by Life Cycle


Sponsor

Hanyang University

Enrollment

500 participants

Start Date

Jan 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Prediction and treatment of pediatric diseases and long-term outcomes through microbiome and multi-omics analysis by life cycle: We aim to demonstrate that a wide range of diseases are associated with gut microbiome dysbiosis and to investigate the subsequent recovery (restoration) or further deterioration of the gut microbiome over time. This study seeks to offer a novel perspective on changes in the gut microbiome, particularly in the context of the gut-lung and gut-brain axes.


Eligibility

Inclusion Criteria1

  • children (including newborns) who have obtained their consent from their guardians

Exclusion Criteria1

  • subjects who did not obtain consent

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Hanyang University Medical Center

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06812091


Related Trials